Birth defects in a cohort of uninfected children born to HIV-infected women;Malformaciones congénitas en una cohorte de niños no infectados, hijos de madres infectadas por el virus de la inmunodeficiencia humana

Anales de Pediatria

Volumn 70, Issue 3, 2009, Pages 253-264

  Fernandez Ibieta M ^a   Ramos Amador, J T ^a   Bellon Cano J M ^b   Gonzalez Tome M I ^c   Guillen Martin S ^a   Navarro Gomez M ^b   De Jose M I ^d   Beceiro, J ^e   Iglesias, E ^a   Prieto, L ^a   Santos, M J ^f   Martinez Guardia N ^f   Roa, M A ^f,g   Regidor, J ^h  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^f HOSPITAL SEVERO OCHOA   (Spain)

^g HOSPITAL DE MÓSTOLES   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Birth defects; HAART; HIV; Mother to child transmission

Indexed keywords

ABACAVIR; AMPRENAVIR; COCAINE; DELAVIRDINE; DIAMORPHINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; METHADONE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE;

ANEMIA; ARTICLE; BIRTH DEFECT; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEWBORN; PREGNANT WOMAN; PREMATURITY; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

CHILD, PRESCHOOL; CONGENITAL ABNORMALITIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 62949103539     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2008.10.021     Document Type: Article

References (38)

1. C. Thorne, D. Patel, D. Fiore, C. Peckham, M.L. Newell on behalf of the European Collaborative Study Mother-to-child transmisión of HIV infection in the era of highly active antiretroviral therapy CID 40 2005 458 465
2. G.P. Taylor, and N. Low-Beer Antiretroviral therapy in pregnancy - a focus on safety Pract Drug Safety 24 2001 683 702
3. M.F. Chersich, M.F. Urban, F.W. Venter, T. Wessels, A. Krause, and G.E. Gray Efavirenz use during pregnancy and for women of child-bearing potential AIDS Res Ther 3 2006 11 Disponible en: URL: www.aidsrestherapy.com/content/3/1/ 11 ]
4. M. De Santis, B. Carducci, L. De Santis, A.F. Cavaliere, and G. Straface Periconcepcional exposure to efavirenz and neural tube defects Arch Intern Med 162 2002 190
5. A. Saitoh, A.D. Hull, P. Franklin, and S.A. Spector Myelomeningocele in an infant with intrauterine exposure to efavirenz J Perinatol 25 2005 555 556
6. C. Thorne, and M.L. Newell Safety of agents used to prevent mother-to-child transmission of HIV Drug Safety 30 2007 203 213
7. M.P. Richardson, D. Osrin, S. Donaghy, N.A. Brown, P. Hay, and M. Sharland Spinal malformations in the fetuses of HIV infected women receiving combination antiretroviral therapy and co-trimoxazole Europ J Obs Gyn Reproduct Bio 93 2000 215 217
8. A. White, R. Eldridge, E. Andrews the Antiretroviral Pregnancy Registry Advisory Committee Birth outcomes following zidovudine exposure in pregnant women: The Antiretroviral Pregnancy Registry Acta Paediatr 421 Supl 1997 86 88
9. O.A. Olivero, G.M. Shearer, C.A. Chougnet, A. Kovacs, A.L. Landay, and R. Baker Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero AIDS 13 1999 919 925
10. E. Capparelli, N. Rakhmania, and M. Mirochnick Pharmacotherapy of perinatal HIV Sem Fetal Neonat Med 10 2005 161 175
11. S.S. Siu, J. Hok-Keung, M.W. Pang, P.Y. Chiu, and T.K. Lau Placental transfer of zidovudine in first trimester of pregnancy Obstet Gynecol 106 2005 824 827
12. S. Blanche, M. Tardieu, P. Rustin, A. Slama, B. Barret, and G. Firtion Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084 1089
13. L. Mofenson, and P. Munderi Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants J Acqui Inmune Defic Syndr 30 2002 200 215
14. GESIDA Recomendaciones de la Secretaría del Plan Nacional sobre el SIDA (SPNS), el grupo de Estudio de Sida (GeSida/SEIMC), la Sociedad Española de Ginecología y Obstetricia (SEGO) y la Asociación Española de Pediatría (AEP) para el seguimiento de la infección por el VIH con relación a la reproducción, el embarazo y la prevención de la transmisión vertical. Disponible en: URL: www.gesida.org
15. H. Watts, D. Li, E. Handelsman, H. Wilson, M. Paul, and M. Foca Assessment of birth defects according to maternal therapy among infants in the women and infants transmission study J Acquir Immune Defic Syndr 44 2007 299 305
16. C. Hankin, C. Thorne, M.L. Peckham Newell the European Collaborative Study Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women J Acquir Immune Defic Syndr 32 2003 380 387
17. C. Newschaffer, J. Cocroft, C. Anderson, W. Hauck, and B. Tuner Prenatal zidovudine use and congenital anomalies in a medicaid population J Acquir Immune Syndr 24 2000 249 256
18. H. Watts, D. Covington, K. Beckerman, P. Garcia, A. Scheuerle, and K. Dominguez Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy Am J Obst Gyn 191 2004 985 992
19. M. Fernandez-Ibieta, J.T. Ramos Amador, S. Guillen Martin, M.I. González-Tomé, M. Navarro Gomez, and E. Iglesias ¿Por qué se infectan aun niños con el virus de la inmunodeficiencia humana en España? An Pediatr (Barc) 67 2007 109 115
20. A. Queisser-Luft, G. Stolz, A. Wiesel, and K. Schlaefer Malformations in newborn: Results based on 30 940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998) Arch Gynecol Obstet 266 2002 163 167
21. EUROCAT, Coding of EUROCAT Subgroups of Congenital Anomalies [citado 15 Mar 2008]. Disponible en: URL: www.eurocat.org]
22. A. Scheuerle, and H. Tilson Birth defect classification by organ system: A novel approach to heighten teratogenic signalling in a pregnancy registry Pharmacoepidemiol Drug Safety 11 2002 465 475
23. J. Warzawski, R. Tubiana, J. Le Chedenac, S. Blanche, J.P. Teglas, and C. Dollfus Mother-to-child transmission despite antiretroviral therapy in the ANRS French perinatal cohort AIDS 22 2008 289 299
24. Feinberg D. More data on safety of antiretrovirals in pregnancy. [citado 15 Mar 2008]. Disponible en: URL: www.accnewsletter.org
25. D. Covington, H. Tilson, J. Elder, and P. Doi Assessing teratogenicity of antiretroviral drugs: Monitoring and analysis plan of the antiretroviral pregnancy registry Pharmacoepidemiol Drug Safety 13 2004 537 545
26. D. Patel, C. Thorne, S. Fiore, M.L. Newell the European Collaborative Study Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr 40 2005 116 118
27. C.L. Townsend, P.A. Tookey, M. Cortina-Borja, and C.S. Peckham Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the United Kingdom and Ireland 1990 to 2003 J Acquir Immune Defic Syndr 42 2006 91 94
28. H. Watts Teratogenicity risk on antiretroviral therapy in pregnancy Curr HIV Report 4 2007 135 140
29. J. Rankin, S. Pattenden, L. Abramsky, P. Boyd, H. Jordan, and D. Stone Prevalence of congenital anomalies in five British regions, 1991-99 Arch Dis Child Fetal Neonatal Ed 90 2005 F374 F379
30. C.M. Da Silva Costa, S.G. Nogueira da Gama, and M. Do Carmo Leal Congenital malformations in Rio de Janeiro, Brazil: Prevalence and associated factors Cad Saude Publica 22 2006 2423 2431
31. S. Dastgiri, D.H. Stone, C. Le-Ha, and W.H. Gilmour Prevalence and secular trend of congenital anomalies in Glasgow, UK Arch Dis Child 86 2002 257 263
32. C. De Vigan, B. Khoshnood, A. Lhomme, V. Vodovar, J. Goujard, and F. Goffinet Prévalence et diagnostic prenatal des malformations en population parisienne J Gynecol Obstet Biol Reprod 34 2005 8 16
33. J. Nazer, T. Aravena, and L. Cifuentes Malformaciones congénitas en Chile. Un problema emergente (periodo 1995-1999) Rev Med Chile 128 2001 600 605
34. M.L. Martínez-Frías, and E. Bermejo Frecuencia basal de defectos congénitos en España y su evolución en el tiempo: utilidad y significado de las distintas cifras de frecuencia Med Clin (Barc) 113 1999 459 462
35. J. Salvador Peral, M.R. García-Miñaur Rica, C. Caballón Fernández, C. Mosquera Tenreiro, E. Baena Díez, and V. García López Registros poblacionales de defectos congénitos en España An Pediatr (Barc) 48 1999 575 582
36. E.R. Esposito, K.H. Horn, R.M. Greene, and M. Pisano An animal model of cigarette smoke-induced in utero growth retardation Toxicology 246 2008 193 202
37. M.L. Fernández-Frías Análisis del riesgo de defectos congénitos debidos a la ingesta de drogas durante el embarazo Med Clin (Barc) 112 1999 41 44
38. C.R. Chao Cardiovascular effects of cocaine during pregnancy Semin Perinatol 20 1996 107 114